newsfilter
← Latest News
GlobeNewswire·

ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update

On-going Phase 2b clinical trial (ASPEN-COVID-19) evaluating rNAPc2 as a potential treatment for COVID-19 DSMC interim analysis of safety and efficacy data from ASPEN-COVID-19 completed with recommendation to continue trial to completion with no modifi